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Summary
In humans, studies of female germ cells are very limited
by ethics. The current study investigated the usefulness
of benign ovarian teratomas as a substitute for ova in
analyses of imprinted genes. Twenty-five human benign
ovarian teratomas were typed with 45 microsatellite
DNAmarkers and classified according to their genotypic
features. Two oppositely imprinted genes, H19 and
SNRPN, were then chosen for analysis of their meth-
ylation states in these tumors. These analyses revealed
that benign ovarian teratomas consist of a mixture of
genetically and epigenetically heterogeneous cell popu-
lations. In contrast to previous reports, we could doc-
ument only one case rising from germ cells by meiosis-
II nondisjunction. H19 and SNRPN were methylated in
individual teratomas to various degrees, ranging from
normal somatic cell to expected ovum levels. The allele
with residual methylation of H19 was consistent with
that methylated in the patient’s blood DNA, thus being
of paternal origin. Degrees ofH19 hypomethylation and
SNRPN hypermethylation increased as the cellular ori-
gin of the tumors advanced in oogenesis and were closely
correlated in individual teratomas. These results could
be best explained by the assumption that the primary
imprinting is a progressively organized process and sug-
gest that the establishment of primary imprints on dif-
ferent genes might be mechanistically linked, even when
those genes are oppositely imprinted.
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Introduction
Parent-of-origin–dependent functional differences be-
tween maternally and paternally derived chromosomes
are referred to as “genomic” or “gametic” imprinting.
An outstanding feature of genomic imprinting is its sta-
ble and reversible heritability. Although the molecular
mechanism of the imprinting is not yet fully unraveled,
the maternal and paternal alleles of a gene must be
marked in the gamete for the appropriate expression
pattern to be assumed and maintained in the embryo.
An excellent candidate for the mark is methylation of
the cytosine residue in CpG dinucleotides (Razin and
Cedar 1994). The most convincing evidence for a role
of methylation in imprinting has been obtained in the
analysis of methylation and expression of several im-
printed genes in methyltransferase-deficient mice (Li et
al. 1993).
Although it is widely accepted that methylation is cru-
cially involved in marking alleles and controlling allele-
specific expression of imprinted genes, pivotal questions
remain with respect to how the imprinting marks are
established and erased during gametogenesis. Methyla-
tion imprints escape a wave of genomewide demethy-
lation and are protected from a wave of global de novo
methylation before and after gastrulation, respectively
(Sto¨ger et al. 1993; Tremblay et al. 1995). Phenotypic
differences between parthenogenetic (benign ovarian ter-
atomas [MIM 166950]) and androgenetic (complete hy-
datidiform moles [MIM 231090]) growths are attrib-
utable in part to this effect. Analysis of such growths
may provide insights into the methylation imprints of
the germ cells from which they were generated.
Benign ovarian teratomas (mature cystic teratomas)
are composed of fully differentiated mature tissues de-
rived from all three germ layers. They contain a cyst
filled with sebaceous material, desquamated squamous
cells, and hair and are thought to arise from defects in
the meiotic process. An early cytogenetic study indicated
that ovarian teratomas were parthenogenetic tumors
that arose from a single germ cell after the first meiotic
division and failure of meiosis II (Linder et al. 1975).
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Figure 1 Cellular origin of the teratomas as inferred from the
genotype analysis. The smaller circle indicates the minor cell popu-
lation in the single tumors. “Pre-M” denotes the premeiotic phase,
“M-I” denotes the meiosis I phase, and “M-II” denotes the meiosis II
phase.
Later studies using chromosomal heteromorphisms and
genetic markers (RFLPs and VNTRs) suggested a di-
versity of mechanisms in their origin (Dahl et al. 1990;
Deka et al. 1990; Surti et al. 1990), and it is now thought
that benign ovarian teratomas can originate from each
stage of female gametogenesis. The exact nature of the
meiotic error that occurred during the formation of a
particular teratoma can be inferred by typing with poly-
morphic DNA markers (fig. 1). Teratomas originating
due to a meiosis I error can be expected to be hetero-
zygous for almost all pericentromeric markers, with ho-
mozygosity for distal markers being an indicator for
crossover events. In contrast, a meiosis II error would
produce teratomas in which all markers near the cen-
tromere are homozygous, with crossover events reflected
by heterozygosity for distal markers. In the present study
we used genotyping and methylation analyses of benign
ovarian teratomas to investigate whether methylation
imprinting of individual genes is an independent and
separated process or shares a common process for dif-
ferent genes.
Patients and Methods
Patients
Samples were obtained from 25 patients with mature
cystic teratomas who were operated on at the Depart-
ment of Obstetrics and Gynecology, Nagasaki University
Hospital. Tumor samples were collected by one individ-
ual, to ensure uniform selection, from July 1996 to April
1998. Informed consent was obtained from patients un-
dergoing surgery. The diagnosis of mature cystic tera-
toma was confirmed in each case by pathology reports.
The teratoma samples were taken from the innermost
cell wall or from the growth nidus of the cyst, with care
being taken not to include any material from the ovarian
capsule, and were washed in sufficient cold saline to
exclude contamination by the patient’s blood. For each
patient, somatic DNA was isolated from a peripheral
blood sample. DNA was extracted as described else-
where (Jinno et al. 1994).
Tissue Culture
Two cases of teratoma (numbers 24 and 25) were
subjected to primary cultures. In brief, tissue samples
were minced and dissociated with a 0.8% collagenase/
0.02%DNase I solution. The cells were grown in Amino
Max C-100 (GIBCO-BRL) at 37C in a humidified at-
mosphere with 5% CO2. Fresh mediumwas added every
4–5 d. Once growth was well established, cells were
subcultured and harvested. DNA was extracted from
cells during the third passage.
Genotyping
A total of 45 polymorphic microsatellite markers (41
CA-repeat and 4 tetranucleotide-repeat markers) were
selected from the Ge´ne´thon databases (Dib et al. 1996)
and from the Cooperative Human Linkage Centermark-
ers (Murray et al. 1994). The selected markers consisted
of 25 pericentromeric markers on 16 chromosomes and
20 nonpericentromeric markers on 3 chromosomes (see
the Appendix). By using the DNA sequencer–assisted
method with fluorescent microsatellite marker DNAs,
we determined the genotypes of each host-teratoma pair
(Mansfield et al. 1994). Genomic DNA samples were
typed for CA-repeat and tetranucleotide-repeat markers
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Figure 2 Examples of electrophoretic patterns in microsatellite-
repeat markers. Two typical cases in each group except group IIb are
demonstrated. B = host-blood DNA; T = tumor-tissue DNA.
Table 1
Summary of DNA Typing of 25 Benign Ovarian Teratomas and
their Classification
CASE
CHROMOSOME STATUS
NO. OF
RECOMBINATIONSa GROUPbHeterozygous Homozygous
1 0 12 0 IIa
2 13 0 0 Ia
3 0 11 0 IIa
4 13 0 0 Ia
5 10 1 6 (3,2,1) Ib
6 14 0 0 Ia
7 9 1 3 (1,2,0) Ib
8 8 4 2 (0,2,0) ND
9 12 0 0 Ia
10 0 9 0 IIa
11 2 9 7 (3,2,2) IIb
12 12 1 8 (5,1,2) Ib
13 11 1 3 (2,0,1) Ib
14 11 0 5 (1,2,2) Ib
15 12 0 0 Ia
16 11 0 0 Ia
17 0 13 0 IIa
18 11 0 4 (2,1,1) Ib
19 14 0 0 Ia
20 10 3 2 (0,0,2) ND
21 8 5 3 (3,0,0) ND
22 0 14 0 IIa
23 0 12 0 IIa
24 12 0 3 (0,1,2) Ib
25 14 0 6 (3,3,0) Ib
a Numbers in parentheses are numbers of recombinations on chro-
mosomes 6, 11, and 15, respectively.
b ND = not determined.
by PCR amplification in a 12.5-ml reaction mixture con-
taining 50 ng of genomic DNA, 1 mM each of Cy5-
labeled sense primer and unlabeled antisense primer (0.2
mM in each dNTP), 1.25 ml buffer, and 0.2510# PCR
U AmpliTaq Gold (PE Biosystems). PCR was performed
in a GeneAmp PCR System 9600 (PE Biosystems), under
the following conditions: 1 cycle at 94C for 10 min; 40
cycles at 94C for 30 s, 55C for 30 s, and 72C for 30
s; and a final elongation cycle at 72C for 10 min. A
mixture of 4 ml of eightfold-diluted PCR product, 3 ml
of loading dye (5 mg dextran blue 2000/ml deionized
formamide), and 1.5 ml each of the suitable sizedmarkers
(Cy5 Sizer; Pharmacia Biotech) was made. This mixture
was denatured at 94C for 5 min and loaded onto Ready
Mix Gel (Pharmacia Biotech) containing 6%acrylamide/
bisacrylamide monomers, 100 mMTris-borate (PH 8.3),
and 1 mM EDTA. The DNA was then electrophoresed
in a running buffer containing 50 mM Tris-borate and
0.5 mM EDTA, with use of an Automated Laser Fluo-
rescent DNA sequencer (Pharmacia Biotech) at 55C and
15 W/gel. The resulting data were analyzed with Frag-
ment Manager Version 1.2 software (Pharmacia Bio-
tech), to determine genotypes for marker loci in each
subset of host-teratoma pairs. By comparing genotypes
of the tumors with those of their hosts, we were able to
group them and to assign the stage in oogenesis from
which each tumor was likely to have originated.
Methylation Analysis
Southern blot analysis ofH19methylationwas carried
out as described elsewhere (Jinno et al. 1996). The
probes (H19 probe 1 and WT1/WIT1 internal control
probe) were also the same as those used in the other
study. In brief, 5 mg of genomic DNA were digested with
PstI and PvuII, then subjected to HpaII digestion (10 U/
mg DNA), fractionated onto a 1.6% agarose gel, and
transferred to nylon membranes. Signal intensities of the
469-bp HpaII-resistant band and the internal control
band were measured on a BAS1000 imaging analyzer
(Fujix).
In addition, the methylation state of SNRPN was ex-
amined at two of the threeNotI sites present in the exon
a-flanking region. Unlike the H19-methylation analysis,
an internal control was not applied because relative
methylation was expressed as ratios of the uncleaved
band to a sum of the cleaved and uncleaved bands. Ge-
nomic DNA was digested with PstI and NotI (15 U/mg
DNA) and separated onto a 1.6% agarose gel. A DNA
probe was made by use of nested primers on the basis
of the GenBank database (accession number U41384).
After hybridization, filters were washed to a final strin-
gency of /0.1% SDS at 60C. PCR conditions0.1# SSC
(GeneAmp PCR System 9600, PE Biosystems) and
primer sequences were as follows: first PCR, 30 cycles
with initial denaturation for 4 min at 94C, subsequent
denaturations for 30 s at 94C, annealing for 30 s at
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Figure 3 Methylation analyses of the H19 and SNRPN genes in teratomas. A, Schematic restriction maps of analyzed regions. Exons are
depicted by unblackened boxes. Probes are indicated by hatched boxes below the lines. Arrows represent the CpG-rich repeated sequences.
Only the analyzed HpaII (H19) and NotI (SNRPN) sites are shown, indicated by vertical thick lines. The polymorphicHhaI (H) site is indicated,
along with primers that were used in the PCR-based methylation analysis. Restriction sites are as follows: Pt = PstI and Pv = PvuII. B, Southern-
blot analysis of H19 methylation. PstI and PvuII-cleaved DNA were subjected to HpaII digestion (lanes 3–11) or MspI digestion (lane 2).
Digestion with PstI/PvuII alone is shown in lane 1. An arrowhead indicates the internal control used to calibrate the loaded amounts of DNA.
The 469-bp PstI-PvuII fragment was quantified. The groups to which the teratomas belong are indicated at the top. “Ov” denotes normal
portion of the ovary from a patient who had a teratoma and “Bl” denotes peripheral blood DNA. C, Southern-blot analysis of SNRPN
methylation. DNA samples were digested with PstI alone (lane 1) or PstI plus NotI (lanes 2–10). D, Changes in methylation states in the H19
(left panel) and SNRPN (right panel) genes, after cultivation. In two cases of teratomas, DNA samples were obtained from cultured cells (C)
or directly from the tumor tissues (T). B = host-blood DNA.
57C, and extension for 30 s at 72C with primers A
and B, with 0.5 mg genomic DNA as template; nested
PCR, 15 cycles at 94C for 30 s, 57C for 30 s, and
72C for 30 s with primers a and b, with 2 ml of 10-
fold diluted first PCR product as template. Primers were
as follows: primer A, 5′-TACCTCCCAGCCACTTCC;
primer B, 5′-TGCACTGCGGCAAACAAGCA; primer
a, 5′-CACTGTCACACCGACTCATC; and primer b, 5′-
TGCCTGACGCATCTGTCTGA.
Allelic Analysis of Methylation
Using the HhaI polymorphism, we examined the
allele specificity of methylation for the candidate re-
gion of the human H19 locus, which has previously
been shown to display a paternal-specific methylation
imprint (Jinno et al. 1996). In brief, genomic DNA
with or without prior digestion with a methyl-sensi-
tive enzyme HpaII was PCR amplified. The product
was restricted with HhaI and separated onto a 4%
polyacrylamide gel. The allele specificity of methyla-
tion of the NotI sites of SNRPN, described above,
was similarly examined with a PCR-based assay with
use of theHpaII/MspI polymorphism in the first intron
of the SNRPN gene (Saitoh et al. 1997).
Results
Genotype Analysis
The genotype in each of 25 benign ovarian teratomas
was compared with that of a peripheral blood sample
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Figure 4 PCR-based methylation assay ofH19. Allele specificity
of H19 methylation in teratomas was examined with the HhaI RFLP.
DNA pretreated with HpaII () or without HpaII () was PCR am-
plified, HhaI digested, and separated onto a 4% polyacrylamide gel.
T = tumor DNA; B = host-blood DNA.
Table 2
Relative Intensities of HpaII- or NotI-Resistant Bands
of the H19 or SNRPN Gene in Teratomas, Compared
with Those in the Host’s Blood DNA
GROUP AND CASEa
RELATIVE INTENSITY OFb
H19 SNRPN
Ia:
4 .84 1.05
6 .91 .98
15 1.17 NA
16 1.12 1.02
19 .78 1.04
Mean  SD .96 .15 1.02 .03
IIa:
1 .84 1.16
3 .48 1.36
10 .48 1.35
17 .72 1.17
22 .54 1.34
23 .65 1.13
Mean  SD .62 .13 1.25 .10
Ib:
5 .53 1.29
12 .40 1.62
13 .46 1.33
18 .31 1.57
24 .59 1.21
24C .00 1.82
25 .21 1.66
25C .03 2.07
Mean  SD .42 .13 1.45 .18
IIb:
11 .36 1.65
Not determined:
20 .72 1.25
21 .63 1.26
a A “C” suffix denotes cultured cells and a case that
therefore was excluded from calculation of the mean
value.
b As determined, in most cases, in two to four ex-
periments. NA = not analyzed.
from their respective hosts. CA-repeat markers were ex-
clusively used in the present study because of their abun-
dance and availability. PCR amplification of dinucleo-
tide repeats yields slippage products that occasionally
render the electrophoretic patterns of the product dif-
ficult to read. However, tetranucleotide repeats, which
give less-ambiguous data, confirmed the preliminary re-
sults of genotyping with CA-repeat markers.
None of the markers that were heterozygous in the
host’s peripheral blood showed complete homozygosity
in the matched teratoma. Instead, there were differences
in relative intensity between the two alleles in the ter-
atoma when compared with that of the corresponding
alleles of the host (fig. 2). Such alterations seem to be
best explained by the presence of at least two cell pop-
ulations with different genotypes in the single tumor.
This interpretation was supported by the observation
that DNA prepared from cultured cells of two teratomas
revealed complete homozygosity at all loci, whereas
DNA directly extracted from the tumors showed only a
shift in relative allele intensity (data not shown). In the
present study, we regarded a consistent difference in al-
lele intensity between the tumor and host for multiple
markers to be evidence of homozygosity, regardless of
the degree of such differences.
The genotype data were used to infer the origins of
these teratomas. Pericentromeric markers were first
used to classify the teratomas into two groups: tera-
tomas showing a heterozygous (group I) or a homo-
zygous (group II) pattern in all or almost all of the
markers. Each group was then subdivided into tera-
tomas showing evidence of recombination at multiple
loci on two or more chromosomes (subgroups Ib and
IIb) or showing no evidence of recombination (sub-
groups Ia and IIa) (table 1). Thus, the origin of each
subgroup of teratomas can be inferred, as given in
figure 1. Teratomas in group Ia may have originated
from premeiotically dividing germ cells as well as from
immature primary oocytes; a somatic-cell origin could
not be completely excluded despite the methylation
patterns for two imprinted genes as described in
“Methylation Analysis,” below. Group IIa includes
teratomas that might have arisen from apparent-
ly immature primary oocytes—perhaps totally devoid
of recombination between homologous chromo-
somes—that may have initiated premature meiotic di-
vision followed by subsequent mitotic division and
cell proliferation. Teratomas in group Ib possibly were
generated from primary oocytes that had proceeded
to undergo meiotic recombination. The group IIb ter-
atomas should have arisen by meiosis II error after
completion of meiosis I. Of the 25 teratomas studied,
seven (28%) belonged to group Ia, six (24%) to group
IIa, eight (32%) to group Ib, and one (4%) to group
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IIb. Three teratomas were “unclassified” under the
above grouping criteria (table 1). Thus, among 25
teratomas, there was only one case whose origin could
be attributed to a failure of meiosis II disjunction. This
incidence is very low compared with previous reports.
Methylation Analysis
Two oppositely imprinted human genes were chosen
for methylation analysis: the paternally imprinted
H19 and maternally imprinted SNRPN. CpG islands
with possible methylation imprints have been identi-
fied in the 5′ upstream region of H19 and in the exon
a and its flanking regions of SNRPN (Sutcliffe et al.
1994; Buiting et al. 1995; Jinno et al. 1996; Kubota
et al. 1996). HpaII sites present in this region of H19
are heavily methylated in sperm and are methylated
only on the paternal allele in somatic cells, whereas
NotI sites of SNRPN are methylated only on the ma-
ternal allele in various tissues.
The methylation status of the HpaII and NotI sites
in those regions of H19 and SNRPN, respectively,
were examined by Southern blot hybridization (fig. 3)
and PCR-based assay of the teratomas (fig. 4). Un-
expectedly, H19 was partially methylated to various
degrees in all teratomas examined (fig. 3B). The 469-
bp HpaII-resistant (i.e., methylated) bands took val-
ues in intensity with a range of 0.21–1.17, compared
with those of the host’s peripheral blood DNA. The
mean  SD values of each group were 0.96 0.15
( ) for Ia, ( ) for IIa, andn = 5 0.62 0.13 n = 6
( ) for Ib, which suggests that the de-0.42 0.13 n = 6
gree of methylation progressively decreased as the pre-
sumptive origin of the tumors advanced through the
stages of oogenesis. SNRPN was also partially meth-
ylated but tended to be more heavily methylated than
in the host’s blood DNA (fig. 3C). The relative inten-
sities of NotI-resistant bands to net intensities (NotI-
resistant bands plus NotI-cleaved bands) had a range
of 0.98–1.66, compared with those of the host’s blood
DNA. The mean values of each group of teratomas
were ( ) for Ia, ) for1.02 0.03 n = 4 1.25 0.10 n = 6
IIa, and ) for Ib, which suggests that,1.45 0.18 n = 6
unlike H19, the methylation of SNRPN progressively
increased as the stage of germ cells from which the
tumors were presumed to have arisen increased (table
2). Consistent with these average findings, there was
a clear reciprocal correlation between methylation
levels of H19 and SNRPN when data for individual
teratomas were plotted (fig. 5). DNA prepared from
cultured cells of two teratomas was found to be ex-
tremely undermethylated in H19 and hypermethy-
lated in SNRPN, whereas the original tumor tissues
showed partial methylation for both genes (fig. 3D).
The allele specificity of partial methylation was ex-
amined with the PCR-based methylation assay. Either
of the H19 alleles was amplified after HpaII digestion
of teratoma DNA, and this was the same allele that
showed resistance to HpaII digestion in the host’s
blood DNA (fig. 4). Analyses of SNRPN gave similar
results; again, the methylated allele in the host’s blood
DNA was predominantly or exclusively amplified in
the teratoma after NotI digestion (data not shown).
Discussion
The germ-cell origin of benign ovarian teratomas is
well established, by features such as homozygosity for
genetic polymorphisms that are heterozygous in the
hosts and crossover events. Our comprehensive ge-
notype analysis of these tumors, using microsatellite-
repeat polymorphisms, suggested the presence of het-
erogeneous cell populations with different genotypes
within individual tumors. Furthermore, DNA pre-
pared from cultured cells of two teratomas showed
homozygosity for markers and extreme undermethy-
lation of H19 and extreme hypermethylation of
SNRPN, whereas the original tumors were partially
methylated in both of the genes. Although it is evident
that selection occurred in cells with different geno-
types during cell culture, it is unclear whether differ-
ences in epigenotype were causatively involved in the
growth selection of cells in the tumors. It is unlikely
that this genetic and epigenetic heterogeneity results
from normal tissue contamination, because (a) the tu-
mors were well isolated from normal tissues, by the
capsule, and (b) DNA obtained from different por-
tions of tumors gave similar results. Rather, this find-
ing seems to provide additional evidence support-
ing the germ-cell origin of benign ovarian teratomas
(fig. 1).
The present study revealed a low incidence (4%) of
teratomas originating from secondary oocytes, a finding
that seems reasonable when the relatively short duration
of the meiosis II phase during oogenesis is considered.
Discrepancies between the current and previous studies
may arise from differences in the methods used to detect
homozygosity (Linder et al. 1975; Dahl et al. 1990; Deka
et al. 1990). First, the choice of polymorphic marker
varied among these studies. Chromosome polymor-
phisms would not distinguish group IIa (MI error) from
group IIb (MII error) teratomas, and RFLP analysis of
DNA polymorphisms gives more-limited information
than microsatellite analyses. Second, the results obtained
by direct analysis of teratoma tissue may differ from
those obtained with cultured cells. In the present study,
cultured cells exhibited homogeneity in both genotypes
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Figure 5 Correlation of the H19 and SNRPN methylations in
teratomas. In comparison to the blood DNA, relative intensities of the
HpaII-resistant band of H19 as shown in figure 3 were plotted against
those of the NotI-resistant band of SNRPN.
and epigenotypes, whereas the original tumor tissues
showed heterogeneity. Although only two teratomas and
two imprinted genes were analyzed in this way, the cul-
tured cells closely matched the expected features of the
female gamete. This finding may be relevant, given that
cytogenetic studies are usually performed in cultured
cells. The molecular basis of chromosome-painting poly-
morphisms/heteromorphisms is unclear, and it is possible
that they are affected by the process of imprinting. Fi-
nally, a third possibility is that differences in environ-
mental as well as genetic factors may influence the in-
cidence with which teratomas arise from each stage of
oogenesis (Eppig et al. 1996).
H19 is a typical example of a paternally imprinted
gene. The gene is heavily methylated in sperm, and only
the paternal allele is methylated in somatic cells. Thus,
hypomethylation of H19 was expected in the benign
ovarian teratomas, because they are derived from female
germ cells. However, teratomas showed various degrees
of methylation ranging from hypomethylation to the
level that is normal for somatic cells. The allele with
residual methylation was always the same as that in the
host’s peripheral blood and was therefore of paternal
origin. These findings suggest that the primary imprint
of H19 is not completely erased until late oogenesis. On
the other hand, SNRPN is a maternally imprinted gene,
with the maternal allele being methylated in somatic
cells, and it was expected to show hypomethylation or
hypermethylation in teratomas depending on the stage
in oogenesis from which each tumor arose. As withH19
methylation, SNRPN showed partial methylation, to
various degrees, from normal somatic-cell level to hy-
permethylation. This observation suggests that themeth-
ylation imprint of SNRPN may not be fully established
until an advanced stage of female gametogenesis. It has
been suggested that epigenetic modification of the Igf2r
gene occurred late in oogenesis in mice, by use of nuclear
transfer techniques (Kono et al. 1996). In a related ex-
periment, the Snrpn gene was shown to be expressed
from the nongrowing oocytes-derived alleles in experi-
mental parthenogenetic embryos, whereas expression of
Snrpn from the fully grown oocytes-derived alleles was
suppressed. By contrast,H19was expressed equivalently
by both the nongrowing and fully grown oocytes-derived
alleles, indicating that H19 imprinting is established
early in mice (Obata et al. 1998). This apparent differ-
ence in timing of H19 imprinting between humans and
mice may result from the sequence divergence in the
corresponding regions proposed to be the site of primary
methylation imprints (Tremblay et al. 1995; Jinno et al.
1996). Another explanation is that the regions analyzed
in methylation states, in the present study, do not strictly
represent the methylation imprints, unlike those iden-
tified in mouse H19 and Igf2r (Sto¨ger et al. 1993; Trem-
blay et al. 1995; Wutz et al. 1997; Thorvaldsen et al.
1998). In this case, they may just be indicators. In either
case, they can be considered to reflect the state of the
primary imprints.
It remains to be ascertained whether the methylation
imprints analyzed here have any bearing on regulated
imprinted expression of the genes studied. In a prelim-
inary experiment, allelic-expression analysis was per-
formed in a limited number of available and informative
RNA samples (data not shown). Biallelic expression of
H19, with varying degrees of difference in intensity be-
tween the alleles, was shown in three group Ia teratomas
and in one group IIb teratoma. This finding is consistent
with the expectation of full expression from thematernal
allele and partial or variable expression from the other
allele. By contrast, monoallelic expression of SNRPN
was observed in two group Ia teratomas (data not
shown). Again, this finding is consistent with the ex-
pectation of methylation of the (maternal) allele and
expression from the other allele, which is methylated in
some cell populations and unmethylated in other
populations.
When the teratomas were grouped according to their
assumed origin-in-stage at oogenesis, the mean intensity
of theHpaII-resistant band forH19 gradually decreased
as the stage of oogenesis advanced. By contrast, themean
intensity of the NotI-resistant band for SNRPN pro-
gressively increased with advancing stage of oogenesis.
Similarly, a clear correlation was obtained betweenH19
undermethylation and SNRPN heavy methylation, as
exhibited in a regression line with regression ratio of
0.912, when their methylation levels in individual ter-
atomas were plotted. Although interpretation of the
above data is complicated by the fact that the teratoma
consists of heterogeneous cell populations, it appears
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that even cells with the same genotype had different
methylation states in H19 and SNRPN. It is tempting
to speculate on the presence of some mechanistic links
in the primary imprinting process directed to the op-
posite aims, that is, activating and protecting frommeth-
ylation. Methylation analyses must be extended to more
imprinted genes to see the relevance of this speculation.
In humans, studies in female germ cells are ethically
very limited. With the assumption that methylation im-
prints are neither erased in somatic cells during cleavage
nor added during somatic development, we have used
benign ovarian teratomas to study the interrelationship
of the methylation states of the imprinted genes H19
and SNRPN during the gametic-imprinting process in
ova. The presence of heterogeneous cell populations in
teratomas may complicate the interpretation of meth-
ylation or expression data on imprinted genes. If the
relationship between the degree of methylation and
grouping of the teratomas seen here can be applied to
other imprinted genes, and if all cultured cells show pu-
rity of genetic and epigenetic nature, as found in our
two cases, then teratomas could be a useful tool for such
studies. That subset of teratomas in which the imprinting
pattern is well established and is as expected for mater-
nal chromosomes may be particularly valuable in this
regard.
Although inferences can be drawn, the precise meth-
ylation states of the imprinted genes in the germ cells
from which the tumors originated is not known, and
our study may instead provide insights into somatic
events in methylation imprinting during tumorigenesis.
For example, such data could be interpreted to indicate
that methylation imprints in the H19 or SNRPN gene
are erased or established in somatic cells during tumor
development. Evidence supporting the erasure of meth-
ylation and de novo methylation in somatic cells is pro-
vided by the de novo methylation of H19 in primary
embryonic fibroblasts rescued from chimeras of female
embryonic germ cells (Tada et al. 1998). In addition,
reprogramming of the human H19 methylation imprint
has been observed in mouse-embryonic carcinoma cell
lines containing a human chromosome 11, introduced
by microcell-mediated chromosome transfer (Mitsuya et
al. 1998). We consider that, collectively, these studies
suggest that primary gametic imprinting may be a pro-
gressive and cumulative process that develops through-
out gametogenesis. Incomplete organization of the im-
print in H19 may permit de novo methylation in some
somatic cells during tumorigenesis, but, because of its
heritability, formation of the complete imprintmay even-
tually be achieved, and thereafter the incidentally ac-
quired methylation may no longer be sustained. A sim-
ilar scenario may be drawn for the imprinting of
SNRPN, but in the opposite direction with respect to
methylation.
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Appendix
Microsatellite DNA Markers Used for Genotype Anal-
ysis of 25 Benign Ovarian Teratomas
In the following list, the tetranucleotide-repeat mark-
ers are underlined.
Pericentromeric Markers
(16 Chromosomes, 25 Loci)
Noncentromeric Markers
(3 Chromosomes, 20 Loci)
D2S113 (cen) D6S1574
D4S2974 (4p12-q12) D6S426
D5S2087 (cen) D6S407 (6q16.3-q23.2)
D6S1573 (6p21-p12) D6S314 (6q16.3-q27
D6S1681 (6q13) D6S1654 (6q25)
D7S691 (7p13-cen) D6S1719 (6q25.2-27
D7S2422 (cen) D6S1590 (6q25.2-27)
D9S1799 D6S281 (6q27)
D11S905 (11p12) D11S922 (11p15.5)
D11S1344 (11p11) D11S1760 (11p15)
D11S4113 (11q13) D11S1349 (11p15.4)
D14S990 (14q11.2) D11S4190 (11p15)
D15S986 (15q12) D11S4152 (11p14)
D15S1002 (15q13-q14) D11S4200 (11q14-p13)
D16S3080 (16q12.1) D11S4176 (11q14)
D18S453 (18p11.2-p11.1) D11S4085 (11q25)
D19S410 (19p13.1) D15S978 (15q15-q21)
D20S884 (20p11-q11.2) D15S988 (15q22-tel)
D21S1899 (21q21) D15S1014 (15q22-tel)
D22S1158 (22p11.2) D15S966 (15q26-tel)
DXS991 (Xp11.21)
D4S1645
D7S1830
D9S1124
D11S2365
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
Cooperative Human Linkage Center, http://lpg.nci.nih.gov/
CHLC/ (for microsatellite markers)
Miura et al.: Dermoid Cyst and Methylation Imprinting 1367
GenBank, http://www.ncbi.nlm.nih.gov/Web/Genbank/index
.html (for DNA probe nested primers [U41384])
Ge´ne´thon, http://www.genethon.fr (for microsatellite markers)
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.gov/Omim (for benign ovarian teratomas [MIM
166950] and complete hydatidiform moles [MIM 231090])
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